EUVIMEDEUVIMED entdecken
Crossref

SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads

Soumyajit Das iD, Khanh Ha Nguyen, Tyler Fritsch, Shambhavi Borde, Els Verhoeyen, Sandro Matosevic iD

The Journal of Immunology · 2026

DOI: 10.1093/jimmun/vkag133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Immunology, 2026. Verfasst von Soumyajit Das und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, United States. Hauptthemen laut MEDLINE: Killer Cells, Natural, Receptors, Chimeric Antigen, Transduction, Genetic, Immunotherapy, Adoptive. Die Arbeit nennt 35 Literaturangaben. Gefördert von: ChadTough DIPG Foundation and the Purdue Institute for Cancer Research.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Reproducible and efficient genetic engineering of human NK cells remains a primary challenge to next-generation chimeric antigen receptor (CAR) therapies, specifically for larger constructs with multiple plasmids and transgenes. Lentiviral vectors (LVs) pseudotyped with baboon envelope (BaEV) outperform vesicular stomatitis virus G protein in transducing hematopoietic stem cells, T cells, B cells, and NK cells, but suffer from fusogenic toxicity in producer cells and lower virion yields (BaEV-TR). Here, we engineer an integrated viral receptor platform that overcomes these constraints and enables transduction of freshly isolated, resting NK cells. First, we generated a Sleeping Beauty–engineered HEK293T packaging cell line stably expressing the nonfusogenic BaEV-TR glycoprotein, enabling consistent and scalable production of high titer BaEV-TR–pseudotyped LVs. Using this system, we generated LVs encoding SLC1A5 and a large (∼9.6 kb) multifunctional CD73-GD2-NKG2D CAR (mCAR). Second, we augmented SLC1A5 expression in freshly-isolated human NK cells using PDK1 inhibitor BX-795 and BaEV-TR-pseudotyped LVs. Rapid SLC1A5 overexpression in NK cells enabled transduction of resting cells without prior expansion and significantly increased NK cell susceptibility to mCAR delivery, achieving robust expression of the complex CAR cassette and preserving NK cell phenotype, cytokine production, degranulation, proliferation, and cytotoxicity against aggressive solid tumor cell targets. This combined approach directly addresses major bottlenecks in CAR-NK cell manufacturing, providing a modular platform for programming NK cells with challenging and large payloads.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Killer Cells, NaturalReceptors, Chimeric AntigenTransduction, GeneticImmunotherapy, AdoptiveAmino Acid Transport System ASCHumansHEK293 CellsAnimalsGenetic VectorsLentivirus

Stichwörter der Autor:innen

CAR-NKSLC1A5baboon-pseudotyped lentivirusnatural killer cells

Substanzen

Receptors, Chimeric AntigenAmino Acid Transport System ASC

Autor:innen und Institutionen

  • Department of Industrial and Molecular Pharmaceutics, Purdue University, West Lafayette, IN, United States.
  • Institute for Cancer Research, Purdue University, West Lafayette, IN, United States.
  • Department of Biological Sciences, Purdue University, West Lafayette, IN, United States.
  • INSERM U1111, Université de Lyon, Lyon, France.
  • INSERM U1065, Lyon, France.
  • Université Côte d'Azur, INSERM, C3M, Nice, France.

ORCID-Profile: Soumyajit Das, Sandro Matosevic

Förderung

  • ChadTough DIPG Foundation and the Purdue Institute for Cancer Research

Zitieren

APA

Das, S., Nguyen, K. H., Fritsch, T., Borde, S., Verhoeyen, E., & Matosevic, S. (2026). SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads. The Journal of Immunology. https://doi.org/10.1093/jimmun/vkag133

Vancouver

Das S, Nguyen KH, Fritsch T, Borde S, Verhoeyen E, Matosevic S. SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads. The Journal of Immunology. 2026. doi:10.1093/jimmun/vkag133

BibTeX
@article{Das2026,
  author = {Das, Soumyajit and Nguyen, Khanh Ha and Fritsch, Tyler and Borde, Shambhavi and Verhoeyen, Els and Matosevic, Sandro},
  title = {SLC1A5 augmentation bypasses NK cell transduction barriers to deliver complex CAR payloads},
  journal = {The Journal of Immunology},
  year = {2026},
  doi = {10.1093/jimmun/vkag133}
}
Kostenlos starten →